OncoPep, Inc. Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
OncoPep, Inc. is a small biotechnology company based in Boston, Massachusetts, focused on developing cancer immunotherapies. The firm pursues two T cell–centric modalities: a multi-antigen peptide vaccine intended to target several tumor-associated antigens, and a multi-tumor antigen adoptive T cell therapy. These approaches can be used either as standalone treatments or in combination with other immunotherapies to enhance anti-tumor activity. Operating in the biotechnology research sector, OncoPep aims to advance cancer immunotherapy by engaging T cells through its therapies. In May 2022, the company appointed Dr. Victor Moyo as Chief Medical Officer.